Welcome to PracticeUpdate! We hope you are enjoying access to a selection of our top-read and most recent articles. Please register today for a free account and gain full access to all of our expert-selected content.
Already Have An Account? Log in Now
Ophthalmic Manifestations of Coronavirus Disease 2019 and Ocular Side Effects Investigational Treatments
abstract
This abstract is available on the publisher's site.
Access this abstract nowPURPOSE OF REVIEW
To compile and report the ocular manifestations of coronavirus disease 2019 (COVID-19) infection and summarize the ocular side effects of investigational treatments of this disease.
RECENT FINDINGS
Conjunctivitis is by far the most common ocular manifestation of COVID-19 with viral particles being isolated from tears/secretions of infected individuals. Multiple therapeutic options are being explored across a variety of medication classes with diverse ocular side effects.
SUMMARY
Eye care professionals must exercise caution, as conjunctivitis may be the presenting or sole finding of an active COVID-19 infection. While no currently studied therapeutic agents have been found to reliably treat COVID-19, early vaccination trials are progressing and show promise. A video abstract is available for a more detailed summary. VIDEO ABSTRACT: http://links.lww.com/COOP/A36.
Additional Info
Ophthalmic Manifestations of Coronavirus Disease 2019 and Ocular Side Effects of Investigational Pharmacologic Agents
Curr Opin Ophthalmol 2020 Sep 01;31(5)403-415, DJ Olson, A Ghosh, AY ZhangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.